Briakinumab Antibody
Briakinumab (ABT-874) is a human monoclonal antibody designed to neutralize interleukin-12 (IL-12) . It has been investigated in preclinical and clinical research for immune-mediated conditions, including psoriasis, inflammatory bowel disease, and multiple sclerosis, through both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
J 695, ABT874, ABT-874, A-796874.0, BSF415977, BSF 415977
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.3 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
143.86 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC419434 20 µg
KRTHB3 (KRT83) (NM_002282) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC420913 20 µg
MST4 (STK26) (NM_001042453) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC422147 20 µg
Sec8 (EXOC4) (NM_001037126) Human Over-expression Lysate
Sign In for Pricing
View Details 